TickerFactsScreenerDevelopers

Intellia Therapeutics, Inc. (NTLA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2014: $7.57M2015: -$21.20M2016: $209.84M2017: $300.60M2018: $277.92M2019: $269.88M2020: $527.07M2021: $1.04B2022: $1.24B2023: $1.05B2024: $871.96M2025: $671.39M$671.39M
2014Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$671.39M-23.0%
2024$871.96M-17.0%
2023$1.05B-15.0%
2022$1.24B+18.8%
2021$1.04B+97.4%
2020$527.07M+95.3%
2019$269.88M-2.9%
2018$277.92M-7.5%
2017$300.60M+43.3%
2016$209.84M+1089.8%
2015-$21.20M-380.2%
2014$7.57M—